BÜHLMANN is a fully independent, medium sized Swiss company. BÜHLMANN is developing and manufacturing unique immunoassays, and we are setting “gold standards” in the market with a series of BÜHLMANN Products like Calprotectin including assays for clinical chemistry analyzers like the turbidimetric Calprotectin assay fCALTM turbo that, in combination with the reliable CALEXTM Cap stool extraction device, is setting a new standard in automation. Another turbidimetric assay is the BÜHLMANN fPELATM turbo Kit for pancreatic elastase, which can be done out of the same CALEXTM Cap using the identical buffer as for Calprotectin. With the CALEXTM Collection Set it is possible that the stool extraction can be done directly at home by the patient. This saves time and efforts for the laboratory since the automated pre-analytics (centrifugation & decapping) as well as the measurements of fecal calprotectin and p-elastase can be done directly from the ready-to-use extracts using the high quality BÜHLMANN assays. On our Quantum Blue® POC system we offer a variety of rapid tests including new, the fecal pancreatic elastase test Quantum Blue® fPELA in addition to the Calprotectin and the TDM tests for Infliximab and Adalimumab as well as Anti- Infliximab and Anti-Adalimumab. With our CE-IVDR marked Flow CAST, we offer outstanding Basophil Activation Test (BAT) in the field of Allergy. In 2023, the Basophil Activation Test (BAT) appeared for the first time in the EAACI guidelines. The EAACI has incorporated this BAT test into its decision-making algorithm as a non-invasive ex vivo functional test that should be performed prior to the Oral Food Challenge (OFC).

In addition, BÜHLMANN is also providing outstanding tests in the field of Neuroimmunology. Our Neuroimmunology portfolio includes the BÜHLMANN GanglioCombi® MAG ELISA, the BÜHLMANN GanglioCombi® Light ELISA, the anti-MAG Antibodies ELISA, the anti-SGPG Antibodies ELISA and the anti-GM1 Antibodies ELISA, offering automated and routine-friendly, CE-IVDR-marked assays for the serological work-up of peripheral neuropathies. Our growing portfolio reflects our commitment to advancing precision diagnostics in emerging areas of laboratory medicine.

As unique as our products are our distribution fields. After more than 30 years of very successful collaboration with DPC, BÜHLMANN is today a leading independent supplier for quality molecular diagnostics solutions. With our longstanding partners Seegene, EntroGen, and Cerca Biotech we can offer fully automated and multiplexed MDx systems for every size of laboratory, including 1st Class technical-, application- and logistics-service. Everything out of One Hand!

BÜHLMANN Laboratories AG
Baselstrasse 55
CH – 4124 Schönenbuch

T +41 61 487 12 12
F +41 61 487 12 34
E info@buhlmannlabs.ch
www.buhlmannlabs.ch